FDA Adverse Event Injury Summary report: N

XACT CAROTID STENT SYSTEM

MDR report key: 1962139 · Received January 17, 2011

Report

Report Number
2024168-2011-00346
Event Type
Injury
Date Received
January 17, 2011
Date of Event
December 17, 2010
Report Date
December 23, 2010
Manufacturer
AV-TEMECULA-CT
Product Code
NIM
PMA / PMN Number
P040038
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
MI, US
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

(B)(4). DURING PROCESSING OF THIS COMPLAINT, ATTEMPTS WERE MADE TO OBTAIN COMPLETE EVENT, PATIENT AND DEVICE INFORMATION. STROKE MAY OCCUR DURING THIS TYPE OF PROCEDURE AND AS LISTED IN THE INSTRUCTIONS FOR USE, STROKE IS A KNOWN POTENTIAL ADVERSE EVENT ASSOCIATED WITH THE USE OF THE PRODUCT. THERE WAS NO DEVICE MALFUNCTION REPORTED THAT COULD HAVE CONTRIBUTED TO THE EVENT. BASED ON AVAILABLE INFORMATION, A DEFINITIVE CAUSE FOR THE REPORTED PATIENT ADVERSE EFFECT AND THE RELATIONSHIP TO THE PRODUCT, IF ANY, CANNOT BE DETERMINED, HOWEVER, THERE WAS NO INDICATION OF ANY PRODUCT DEFICIENCIES WHICH COULD HAVE CONTRIBUTED TO THE OUTCOME OF THE PROCEDURE.

Description of Event or Problem · 1

IT WAS REPORTED VIA A TRIAL THAT ONE DAY POST XACT STENT IMPLANTATION IN THE LEFT INTERNAL CAROTID ARTERY, THE PATIENT EXPERIENCED A CEREBROVASCULAR ACCIDENT IN THE RIGHT MIDLINE PONTINE WITH DIPLOPIA. TREATMENT INCLUDED CONTINUATION OF ASPIRIN, CLOPIDOGREL AND PROLONGED HOSPITALIZATION. THE PATIENT'S CONDITION IS CONTINUING BUT IMPROVED. THE PATIENT WAS DISCHARGED HOME FIVE DAYS POST PROCEDURE. THOUGH REQUESTED, NO ADDITIONAL INFORMATION WAS PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 XACT CAROTID STENT SYSTEM CAROTID STENT SYSTEM NIM AV-TEMECULA-CT 0101961

Patients

Seq Age Sex Outcome Treatment
1 81 YR Hospitalization| S EMBOSHIELD NAV6HEPARINASPIRINCLOPIDOGREL